|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 126.4 USD | +0.48% |
|
+2.14% | +15.99% |
| Jul. 03 | Stocks to watch as Biden and Trump vie for presidency | RE |
| Jul. 01 | Merck, Orion Convert Ongoing Collaboration Into Exclusive Global License for Opevesostat | MT |
Financials (USD)
| Sales 2024 * | 64.17B | Sales 2025 * | 68.64B | Capitalization | 320B |
|---|---|---|---|---|---|
| Net income 2024 * | 19.51B | Net income 2025 * | 22.25B | EV / Sales 2024 * | 5.28 x |
| Net Debt 2024 * | 18.6B | Net Debt 2025 * | 7.28B | EV / Sales 2025 * | 4.77 x |
| P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
14.1
x | Employees | 71,000 |
| Yield 2024 * |
2.45% | Yield 2025 * |
2.59% | Free-Float | 70.77% |
Latest transcript on Merck & Co., Inc.
| 1 day | +0.48% | ||
| 1 week | +2.14% | ||
| Current month | +2.14% | ||
| 1 month | -3.23% | ||
| 3 months | -1.20% | ||
| 6 months | +7.87% | ||
| Current year | +15.99% |
| Managers | Title | Age | Since |
|---|---|---|---|
Robert Davis
CEO | Chief Executive Officer | 57 | 14-03-31 |
| Director of Finance/CFO | 55 | 89-12-31 | |
Dave Williams
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tom Glocer
BRD | Director/Board Member | 63 | 07-11-26 |
Pamela Craig
BRD | Director/Board Member | 67 | 15-08-31 |
Inge Thulin
BRD | Director/Board Member | 69 | 18-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 14.34% | 208 M€ | +14.63% | - | |
| 5.61% | 21 M€ | +10.60% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-05 | 126.4 | +0.48% | 6,786,713 |
| 24-07-03 | 125.8 | -1.46% | 4,002,054 |
| 24-07-02 | 127.7 | -0.14% | 5,645,359 |
| 24-07-01 | 127.9 | +3.31% | 11,532,966 |
Delayed Quote Nyse, July 05, 2024 at 04:00 pm EDT
More quotes
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.99% | 320B | |
| +56.89% | 823B | |
| +39.52% | 627B | |
| -6.55% | 353B | |
| +7.92% | 295B | |
| +13.74% | 239B | |
| +13.83% | 220B | |
| -0.49% | 219B | |
| +7.94% | 167B | |
| -2.57% | 159B |
- Stock Market
- Equities
- MRK Stock